Tirzepatide, a novel medication, is sparking considerable interest within the medical community. It works differently from existing diabetes treatments , targeting multiple receptors involved in glucose regulation and satiety. Initial studies have demonstrated remarkable efficacy in lowering blood sugar in individuals with adult-onset diabetes and,